Research & Clinical Trials
Clinical Innovation and Research Institute
Memorial Hermann is dedicated to improving the health of the people in our community. Providing the best patient care is an important part of that goal. While the face of healthcare will continue to change in coming years, one fact remains: the role of clinical research will remain vitally important to the future of medicine.
The Clinical Innovation & Research Institute (CIRI) facilitates the promotion and establishment of collaborative relationships between Memorial Hermann-Texas Medical Center, The University of Texas Health Science Center at Houston (UTHealth) Medical School, Memorial Hermann, private practice clinics and the community.
We foster collaborative partnerships between clinicians, academicians, industry and public sectors to conduct and produce meaningful, quality research to benefit society.
In 2011, Memorial Hermann reached an unparalleled research milestone of 1,000 studies across the system. The significant growth of research at Memorial Hermann is due to several factors, including:
Current Memorial Hermann research studies involve all service lines, with particular focus on the areas of neurology and neurosurgery, cardiology and cardiovascular surgery, oncology, pediatrics and neonatology, trauma, neuro-rehabilitation and advocacy for persons with disabilities. Search for a research study or clinical trial.
The research is funded as follows:
The high volume of in-house research conducted in the Memorial Hermann system has many benefits for healthcare providers and their patients, including:
The leadership of the Clinical Innovation & Research Institute includes:
Cheryl M. Chanaud, Ph.D., C.C.R.P.
Susmitha K. Gadde, M.B.B.S., M.B.A., C.C.R.P.
To further medical knowledge by encouraging and supporting translational and clinical research in order to improve the health of the community and provide innovative, breakthrough treatments to our patients.
To contact the Clinical Innovation and Research Institute, call (713) 704-4226 or e-mail us.